These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23423941)

  • 1. [Effects of pharmacy market deregulation regarding patient-centred drug care in Germany from a health economics perspecitve].
    Rumm R; Böcking W
    Dtsch Med Wochenschr; 2013 Mar; 138(9):441-4. PubMed ID: 23423941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany.
    Stargardt T; Schreyögg J; Busse R
    Health Policy; 2007 Nov; 84(1):30-8. PubMed ID: 17553587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing competition in the pharmacy sector: lessons from Iceland and Norway.
    Anell A; Hjelmgren J
    Appl Health Econ Health Policy; 2002; 1(3):149-56. PubMed ID: 14619266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the German Act on the reform of the market for medicinal products (AMNOG) on the quality of neurological and psychiatric treatment].
    Hamer H; Meyer-Lindenberg A
    Nervenarzt; 2016 Apr; 87(4):351-2. PubMed ID: 27025218
    [No Abstract]   [Full Text] [Related]  

  • 6. Competition in the German pharmacy market: an empirical analysis.
    Heinsohn JG; Flessa S
    BMC Health Serv Res; 2013 Oct; 13():407. PubMed ID: 24112461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition and antitrust enforcement in the changing pharmaceutical marketplace.
    Whitener MD
    Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998
    [No Abstract]   [Full Text] [Related]  

  • 8. Deregulating the pharmacy market: the case of Iceland and Norway.
    Anell A
    Health Policy; 2005 Dec; 75(1):9-17. PubMed ID: 16298225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Globalization in the pharmaceutical industry, Part II.
    Casadio Tarabusi C; Vickery G
    Int J Health Serv; 1998; 28(2):281-303. PubMed ID: 9595345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsettling drug patent settlements: a framework for presumptive illegality.
    Carrier MA
    Mich Law Rev; 2009 Oct; 108(1):37-80. PubMed ID: 20535881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Legislation or market forces? Apothecaries and druggists in the interwar period].
    Kruithof B
    Tijdschr Geschied Geneeskd Natuurwet Wiskd Tech; 1999; 22(1):34-45. PubMed ID: 21141305
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of the German Act on the Reform of the Market for Medicinal Products for psychopharmacotherapy].
    Gründer G
    Nervenarzt; 2016 Apr; 87(4):356-66. PubMed ID: 26983820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry competition.
    Chambers DW
    J Am Coll Dent; 1997; 64(3):47-51. PubMed ID: 9420388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical consultations in community pharmacies: utility of the Roter Interaction Analysis System to study pharmacist-patient communication.
    Cavaco A; Roter D
    Int J Pharm Pract; 2010 Jun; 18(3):141-8. PubMed ID: 20509347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Generic Medicines--Health Network Communications' Second Annual Summit.
    Burck B
    IDrugs; 2008 May; 11(5):328-30. PubMed ID: 18465671
    [No Abstract]   [Full Text] [Related]  

  • 17. [Marketing in hospitals and practices: from theory to implementation].
    Mattmüller R; Gebauer J
    Urologe A; 2011 Dec; 50(12):1560-5. PubMed ID: 22113547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.
    Kravitz RL; Bell RA
    Clin Pharmacol Ther; 2007 Oct; 82(4):360-2. PubMed ID: 17851573
    [No Abstract]   [Full Text] [Related]  

  • 19. An empirical analysis of the multimarket contact theory in pharmaceutical markets.
    Coronado J; Jiménez-Martín S; Marín PL
    Eur J Health Econ; 2014 Jul; 15(6):623-43. PubMed ID: 23818281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Germany's Novartis Chief proposes "More competition through decentralized contracts"].
    Kosche D; Färber L
    MMW Fortschr Med; 2010 Aug; 152(31-33):6-7. PubMed ID: 20828056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.